Skip to main content

Table 1 Circulating concentrations (mean ± SD) of measured parameters in patients with dengue serotype-2 virus infection during the febrile stage, defervescence and convalescence (N = 15), in healthy controls (N = 20) and in non-dengue febrile controls (N = 15)

From: Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection

Parameters Febrile Defervescence Convalescence Healthy controls Non-dengue febrile controls
Plasma LTB4 (p mol/μmol AA) 0.35 (0.35)b 0.38 (0.34)b 0.01 (0.02)c 0.01 (0.01)c 0.17 (0.12)d
Serum hsCRP (mg/L) 6.10 (6.70)b 3.30 (3.00)b 0.60 (1.50)c 1.02 (1.01)c 3.36 (3.69)b
Plasma arachidonic acid (μg/mL) 89.0 (26.4)a 95.8 (24.3)a 110.0 (20.2)a 86.5 (19.7)a 87.7 (22.5)a
Plasma phospholipase A2 activity (nmol/ min/mL) 4.3 (0.9)a 4.4 (1.0)a 4.2 (0.9)a 4.2 (1.1)a -
  1. Data are summarized as mean (standard deviation).
  2. aNormally distributed data with the same subscripts are not significantly different with each other using one-way ANOVA analyses with Bonferroni adjustment.
  3. b,c,dNon-parametric data with the same subscripts are not significantly different with each other using Kruskal-Wallis analysis with Dunn’s adjustment.